Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04646044
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2020-11-14
Brief Title:
A Placebo Controlled Trial of Bempegaldesleukin BEMPEG NKTR-214 With Standard of Care in Patients With Mild COVID-19
Sponsor:
Nektar Therapeutics
Organization:
Nektar Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-18
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-14
First Submit QC Date:
November 24 2020
Study First Post Date:
2020-11-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-03-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-05
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL